Atossa Therapeutics logo

Atossa Therapeutics share price today

(ATOS)

Atossa Therapeutics share price is $0.96 & ₹82.31 as on 3 Jan 2025, 2.30 'hrs' IST

$0.96

0.02

(1.69%)

Market is closed - opens 8 PM, 03 Jan 2025

View live Atossa Therapeutics share price in Dollar and Rupees. Guide to invest in Atossa Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Atossa Therapeutics. Get details on the Indian mutual funds that are investing in Atossa Therapeutics. Get Analyst recommendations and forecasts along with all the Atossa Therapeutics's financials.

Atossa Therapeutics share price movements

  • Today's Low: $0.94
    Today's High: $0.99

    Day's Volatility :4.53%

  • 52 Weeks Low: $0.77
    52 Weeks High: $2.31

    52 Weeks Volatility :66.48%

Atossa Therapeutics Returns

PeriodAtossa Therapeutics IncIndex (Russel 2000)
3 Months
-35.78%
0.0%
6 Months
-13.39%
0.0%
1 Year
3.75%
0.0%
3 Years
-45.11%
-21.2%

Atossa Therapeutics Key Statistics

in dollars & INR

Previous Close
$0.9441
Open
$0.9501
Today's High
$0.9894
Today's Low
$0.9446
Market Capitalization
$118.8M
Today's Volume
$1.2M
52 Week High
$2.31
52 Week Low
$0.7744
Revenue TTM
$0.0
EBITDA
$-29.5M
Earnings Per Share (EPS)
$-0.21
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-31.3%

How to invest in Atossa Therapeutics from India?

It is very easy for Indian residents to invest directly in Atossa Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Atossa Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Atossa Therapeutics or ATOS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Atossa Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Atossa Therapeutics shares which would translate to 0.893 fractional shares of Atossa Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Atossa Therapeutics, in just a few clicks!

Returns in Atossa Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Atossa Therapeutics investment value today

Current value as on today

₹1,08,469

Returns

₹8,469

(+8.47%)

Returns from Atossa Therapeutics Stock

₹5,495 (+5.49%)

Dollar Returns

₹2,975 (+2.97%)

Indian investors sentiment towards Atossa Therapeutics

193%

Period: Oct 4, 2024 to Jan 2, 2025. Change in 30 Days versus previous period

Search volume for Atossa Therapeutics on INDmoney from India has grown in the last 30 days as on Jan 3, 2025. 193% more investors are searching Atossa Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Atossa Therapeutics

  • BlackRock Inc

    7.31%

  • Vanguard Group Inc

    5.25%

  • Geode Capital Management, LLC

    2.24%

  • State Street Corp

    1.38%

  • Renaissance Technologies Corp

    1.04%

  • Northern Trust Corp

    0.76%

Analyst Recommendation on Atossa Therapeutics

Buy

    90%Buy

    10%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for Atossa Therapeutics(by analysts ranked 0 to 5 stars)

Based on 10 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
9
9
8
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Atossa Therapeutics

What analysts predicted

Upside of 525.0%

Current:

$0.96

Target:

$6.00

Insights on Atossa Therapeutics

  • Price Movement

    In the last 7 days, ATOS stock has moved down by -10.9%
  • ATOS vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 20.7% return, outperforming this stock by 19.7%
  • ATOS vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 38.8% return, outperforming this stock by 79.8%

Atossa Therapeutics Technicals Summary

Sell

Neutral

Buy

Atossa Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Atossa Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Atossa Therapeutics Inc
-23.24%
-13.39%
3.75%
-45.11%
-40.25%
Regeneron Pharmaceuticals, Inc.
-4.97%
-31.12%
-21.91%
15.48%
91.62%
Biontech Se
-1.42%
42.28%
6.01%
-49.15%
155.61%
Alnylam Pharmaceuticals, Inc.
-6.56%
-6.26%
22.36%
42.41%
102.91%
Vertex Pharmaceuticals Incorporated
-11.88%
-15.14%
-3.23%
81.51%
79.75%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Atossa Therapeutics Inc
NA
NA
0.0
-0.21
-0.31
-0.2
NA
0.59
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Atossa Therapeutics Inc
Buy
$118.8M
-40.25%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
91.62%
17.61
33.61%
Biontech Se
Buy
$27.3B
155.61%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
102.91%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
79.75%
32.84
-4.51%

About Atossa Therapeutics

atossa therapeutics, inc. develops and markets medical devices, laboratory tests, and therapeutics to address breast health conditions in the united states. the company's lead program is the development of endoxifen, an active metabolite of tamoxifen which is in phase ii studies to treat and prevent breast cancer. it is also developing intraductal microcatheter technology to target the delivery of therapies, including fulvestrant, immunotherapies, and chimeric antigen receptor t-cell therapies, directly to the site of breast cancer. the company was formerly known as atossa genetics inc. and changed its name to atossa therapeutics, inc. in january 2020. atossa therapeutics, inc. was founded in 2009 and is headquartered in seattle, washington.
Organization
Atossa Therapeutics
Employees
12
CEO
Dr. Steven C. Quay FCAP, M.D., Ph.D.
Industry
Health Technology

Management People of Atossa Therapeutics

NameTitle
Dr. Steven C. Quay FCAP, M.D., Ph.D.
Chairman, CEO & President
Ms. Heather Rees CPA
Chief Financial Officer
Ms. Delly Behen P.H.R.
Senior Vice President of Administration & HR
Mr. Michael Parks
Vice President of Investor & Public Relations
Dr. Richard Graydon M.D., Ph.D.
Interim Chief Medical Officer

Important FAQs about investing in Atossa Therapeutics from India :

What is Atossa Therapeutics share price today?

Atossa Therapeutics share price today stands at $0.96, Open: $0.95 ; Previous Close: $0.94 ; High: $0.99 ; Low: $0.94 ; 52 Week High: $2.31 ; 52 Week Low: $0.77. The stock opens at $0.95, after a previous close of $0.94. The stock reached a daily high of $0.99 and a low of $0.94, with a 52-week high of $2.31 and a 52-week low of $0.77.

Can Indians buy Atossa Therapeutics shares?

Yes, Indians can invest in the Atossa Therapeutics (ATOS) from India.

With INDmoney, you can buy Atossa Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Atossa Therapeutics at zero transaction cost.

How can I buy Atossa Therapeutics shares from India?

It is very easy to buy Atossa Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Atossa Therapeutics be purchased?

Yes, you can buy fractional shares of Atossa Therapeutics with INDmoney app.

What are the documents required to start investing in Atossa Therapeutics stocks?

To start investing in Atossa Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Atossa Therapeutics

Today’s highest price of Atossa Therapeutics (ATOS) is $0.99.

Today’s lowest price of Atossa Therapeutics (ATOS) is $0.94.

What is today's market capitalisation of Atossa Therapeutics

Today's market capitalisation of Atossa Therapeutics ATOS is 118.8M

What is the 52 Week High and Low Range of Atossa Therapeutics

  • 52 Week High

    $2.31

  • 52 Week Low

    $0.77

What are the historical returns of Atossa Therapeutics?

  • 1 Month Returns

    -23.24%

  • 3 Months Returns

    -13.39%

  • 1 Year Returns

    3.75%

  • 5 Years Returns

    -40.25%

Who is the Chief Executive Officer (CEO) of Atossa Therapeutics

Dr. Steven C. Quay FCAP, M.D., Ph.D. is the current Chief Executive Officer (CEO) of Atossa Therapeutics.